Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-023862

Options or other derivatives

  • CMO and Head of R&D acquired 40,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PRASAD SUYASH CMO and Head of R&D 2022-04-06 Grant or award · Employee Stock Option (right to buy) +40,325 40,325 D
Loading xslF345X03/doc4.xml…